Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on WhiteHawk Capital Partners — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
WhiteHawk Capital Partners Provides $350 million Credit Facility to Nephron Pharmaceuticals
Jan 10, 2025•over 1 year ago
Contract Type
partnership
Description
WhiteHawk Capital Partners, LP has entered into an agreement with Nephron Pharmaceuticals, LLC to provide a $350 million asset-based credit facility. Nephron will utilize the proceeds to support a recapitalization and liquidity for continued growth.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months